SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Podrobná bibliografie
Hlavní autor:	Meem, Manila
Další autoři:	Akter, Dr. Raushanara
Médium:	Diplomová práce
Jazyk:	English
Vydáno:	Brac University 2023
Témata:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
On-line přístup:	http://hdl.handle.net/10361/18081

Podobné jednotky

A review on potential of PARP inhibitors in the treatment of prostate cancer
Autor: Islam, Saidul
Vydáno: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
Autor: Jahan, Nusrat
Vydáno: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Flora, Sanzida Alam
Vydáno: (2024)

Immunotherapy in the Management of Lung Cancer
Autor: Tasnim, Humayra
Vydáno: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Autor: Ratu, Tabassum
Vydáno: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
Autor: Emon, Kamrul Hasan
Vydáno: (2022)

Identification of FAP inhibitors using in silico simulation study
Autor: Deeba, Maliha Tasnim
Vydáno: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
Autor: Oshin, Sadia Afrin
Vydáno: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Autor: Karim, Azrin
Vydáno: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Autor: Mirza, Maisa Tasnim
Vydáno: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Autor: Khan, Muidul Hasan
Vydáno: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Autor: Haque, Mushfiqul
Vydáno: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Autor: Islam, Nahidul
Vydáno: (2023)

A review on targeted therapies for lung cancer
Autor: Ashraf, Anushey
Vydáno: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Autor: Afroza, Halima
Vydáno: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Autor: Ishrat, Nowshin
Vydáno: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Autor: Sorno, Rubina Haque
Vydáno: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
Autor: Mahin, Md. Tamjidur Rahman
Vydáno: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Autor: Alam, Kazi Tasnuva
Vydáno: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Autor: Fred, Namanda Rogers
Vydáno: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Autor: Khandker, Tahia Anjum
Vydáno: (2024)

Synthesis and sar o acne medication
Autor: Naureen, Tasnia
Vydáno: (2024)

HPLC method development for the analysis of linagliptin
Autor: Mimiya, Ruhani Amrin
Vydáno: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Autor: Paul, Pulock
Vydáno: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Autor: Kamal, Tasnova
Vydáno: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Autor: Tania, Umme
Vydáno: (2023)

Trend in approval of targeted biologics in the last two decades
Autor: Siddika, Khadiza
Vydáno: (2024)

Breast cancer therapy through Liposomal drug delivery system
Autor: Ome, Nusrat Jahan
Vydáno: (2024)

Epigenetic therapy in cancer
Autor: Abid, Md. Shadman Ridwan
Vydáno: (2021)

A review on triple-negative breast cancer and its potential treatment
Autor: Niasa, Jannatul Ferdous
Vydáno: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Autor: Razna, Amrin Islam
Vydáno: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Autor: Chakraborty, Anuradha
Vydáno: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Autor: Nahar, Kamrun
Vydáno: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Autor: Nashrah, Zannatul
Vydáno: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
Autor: Hoque, Syeda Mehren
Vydáno: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Autor: Parvez, Safi
Vydáno: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
Autor: Sarkar, Onusree
Vydáno: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Autor: Hasan, Amit
Vydáno: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
Autor: Dowla, Rumana, a další
Vydáno: (2022)